Novel Agents in Early Trials for Breast Cancer

from Cancer Network Podcasts · host Cancer Network

We speak with Dr. Sara Hurvitz, director of the breast cancer program at the University of California in Los Angeles. Dr. Hurvitz is actively involved in translational phase I/II breast cancer clinical trials as well as in research to better define distinct types of breast tumors to better design novel targeted therapies.

Episode metadata supplied by the publisher feed · Published Jul 11, 2012

Embed this episode

Attribution link and audio player

NOW PLAYING

Novel Agents in Early Trials for Breast Cancer

0:00 12:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cancer Network Podcasts?

This episode is 12 minutes long.

When was this Cancer Network Podcasts episode published?

This episode was published on July 11, 2012.

Can I download this Cancer Network Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!